Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pietrantonio

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Reply to the letter to the editor 'new life for retrospective study in the precision oncology era' by Orlandi et alF Pietrantonio, C Cremolini
Journal of Internal Medicine|January 1, 1997
Delayed hypersensitivity to flurbiprofenA Romano, F Pietrantonio
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2026
Long-term survival outcomes with immune checkpoint inhibition in PD-L1 low or intermediate expressing gastroesophageal adenocarcinomaJ J Zhao, F Pietrantonio
ESMO Open|September 4, 2025
Reply letter to comments on: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trialR Fazio, G Randon, F Pietrantonio
ESMO Gastrointestinal Oncology|April 17, 2026
Highlights in oesophagogastric cancers from ESMO congress 2025A Petrillo, F Pietrantonio, T Fleitas-Kanonnikoff
Contact Dermatitis|October 1, 1992
Delayed hypersensitivity to cefuroximeA Romano, F Pietrantonio, M Di Fonso, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 28, 2012
[State of emergency plans for massive influx of injured (PEMAF) in Italian hospitals. Pilot study]D D'Alessandro, M R Fizzano, C Barletta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2012
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306F Pietrantonio, M C Garassino, V Torri, et al.
Cancer Letters|November 5, 1990
Unusual reaction to chlorambucil: a case reportF Pietrantonio, L Moriconi, F Torino, et al.
Canadian Journal of Microbiology|June 1, 1988
Locomotory characteristics of Treponema denticolaF Pietrantonio, P B Noble, R Amsel, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Reply to the letter to the editor 'new life for retrospective study in the precision oncology era' by Orlandi et alF Pietrantonio, C Cremolini
Journal of Internal Medicine|January 1, 1997
Delayed hypersensitivity to flurbiprofenA Romano, F Pietrantonio
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2026
Long-term survival outcomes with immune checkpoint inhibition in PD-L1 low or intermediate expressing gastroesophageal adenocarcinomaJ J Zhao, F Pietrantonio
ESMO Open|September 4, 2025
Reply letter to comments on: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trialR Fazio, G Randon, F Pietrantonio
ESMO Gastrointestinal Oncology|April 17, 2026
Highlights in oesophagogastric cancers from ESMO congress 2025A Petrillo, F Pietrantonio, T Fleitas-Kanonnikoff
Contact Dermatitis|October 1, 1992
Delayed hypersensitivity to cefuroximeA Romano, F Pietrantonio, M Di Fonso, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 28, 2012
[State of emergency plans for massive influx of injured (PEMAF) in Italian hospitals. Pilot study]D D'Alessandro, M R Fizzano, C Barletta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2012
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306F Pietrantonio, M C Garassino, V Torri, et al.
Cancer Letters|November 5, 1990
Unusual reaction to chlorambucil: a case reportF Pietrantonio, L Moriconi, F Torino, et al.
Canadian Journal of Microbiology|June 1, 1988
Locomotory characteristics of Treponema denticolaF Pietrantonio, P B Noble, R Amsel, et al.
Pageof 8